A Head-to-Head Comparison Study of the First-Day Performance of Two Factory-Calibrated CGM Systems
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Traditional continuous glucose monitoring (CGM) systems require multiple, user-conducted sensor calibrations daily to account for the drift in sensor performance.1 The emerging of factory-calibrated CGM systems such as Abbott FreeStyle Libre 2 (FSL2)2 and Dexcom G6 (G6) CGM3 eliminates the need for user calibration and benefits patients by removing the inconvenience and taking away a significant source of error from sensor calibration.1 Factory calibration shifts the burden to manufacturers to improve sensor stability and reduce process variability to achieve consistent individual sensor behavior.4 During the first day of operation, CGM sensors are also susceptible to the host immune reaction to insertion-induced wound, while the sensors are still stabilizing from a packaging state to the subcutaneous environment.5 Past studies have shown increased mean absolute relative difference (MARD) during the first day of sensor operation, which improves over wear duration.3 This study compares the performance of FSL2 and G6 CGM during the first day of sensor operation. The study compared the performance of each system to venous plasma glucose reference measurements. Twenty-five subjects at one clinical research site in the United States wore one FSL2 sensor on the back of the upper arm and one G6 sensor on the abdomen. Both sensors were used with no additional manual calibrations. Subjects underwent venous Yellow Spring Instrument 2300 Stat Plus Glucose Analyzer (YSI) sampling every 1…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This category of CGM performance specified by the U.S. FDA is the strictest accuracy standard defined by any regulatory agency in the world. 16”
From Importance of FDA-integrated continuous glucose monitors to ensure accuracy of continuous glucose monitoring (2025) · cites this paper as [25]
In the citing paper
“Other important issues to be analyzed for a comprehensive evaluation of CGM systems include sensor stability, calibration stability, threshold alert reliability for hypo- and hyperglycemia, sensor survival, and data availability. 25”
From Importance of FDA-integrated continuous glucose monitors to ensure accuracy of continuous glucose monitoring (2025) · cites this paper as [25]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 6 · Cited by 18
Metadata
- Authors
- Denham, D.
- Affiliations
- Clinical Trials of Texas (US)
- Corresponding author
- Denham, Douglas
- ORCID
- Denham, Douglas
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2020-01-08
- Volume
- 14
- Issue
- 2
- Pages
- 493-495
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC7196870
- OpenAlex
- W2999006319
- Cited by
- 18
- References
- 6
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 5
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Abbott Diabetes Care
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- continuous glucose monitoring, factory calibration, diabetes management
- MeSH terms
- Manufacturing and Industrial Facilities, Glycemic Control, Blood Glucose, Calibration, Diabetes Mellitus, Type 1, Humans, Insulin Infusion Systems, Reference Standards, Time Factors, Blood Glucose Self-Monitoring, Reproducibility of Results, Biosensing Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Head-to-Head Comparison Study of the First-Day Performance of Two Factory-Calibrated CGM Systems. https://app.cochat.ai/papers/10.1177/1932296819895505
- The paper
- Denham, D. (2020). A Head-to-Head Comparison Study of the First-Day Performance of Two Factory-Calibrated CGM Systems. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296819895505
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.